Pathology and recent pathogenetic studies in human graft-versus-host disease - PubMed (original) (raw)
Review
Pathology and recent pathogenetic studies in human graft-versus-host disease
G E Sale. Surv Synth Pathol Res. 1984.
No abstract available
Similar articles
- Alloimmunity and immunosuppression in human graft-versus-host disease.
Tsoi MS. Tsoi MS. Surv Synth Pathol Res. 1984;3(3):275-80. doi: 10.1159/000156932. Surv Synth Pathol Res. 1984. PMID: 6387855 Review. No abstract available. - Epithelial class II antigen expression in cutaneous graft-versus-host disease.
Beschorner WE, Farmer ER, Saral R, Stirling WL, Santos GW. Beschorner WE, et al. Transplantation. 1987 Aug;44(2):237-43. doi: 10.1097/00007890-198708000-00013. Transplantation. 1987. PMID: 3307048 - Acute and chronic graft versus host disease: histopathological evidence for two distinct pathogenetic mechanisms.
Snover DC. Snover DC. Hum Pathol. 1984 Mar;15(3):202-5. doi: 10.1016/s0046-8177(84)80180-x. Hum Pathol. 1984. PMID: 6698540 No abstract available. - Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules.
van Els CA, Zantvoort E, Jacobs N, Bakker A, van Rood JJ, Goulmy E. van Els CA, et al. Bone Marrow Transplant. 1990 Jun;5(6):365-72. Bone Marrow Transplant. 1990. PMID: 2142441 - Acute graft-vs-host disease: pathobiology and management.
Goker H, Haznedaroglu IC, Chao NJ. Goker H, et al. Exp Hematol. 2001 Mar;29(3):259-77. doi: 10.1016/s0301-472x(00)00677-9. Exp Hematol. 2001. PMID: 11274753 Review.
Cited by
- Graft-versus-Host Disease of the Gut: A Histologic Activity Grading System and Validation.
Myerson D, Steinbach G, Gooley TA, Shulman HM. Myerson D, et al. Biol Blood Marrow Transplant. 2017 Sep;23(9):1573-1579. doi: 10.1016/j.bbmt.2017.05.017. Epub 2017 May 19. Biol Blood Marrow Transplant. 2017. PMID: 28533059 Free PMC article. - Keratinocyte dysplasia in hematopoietic stem cell transplantation recipients in the day-28-to-84 posttransplantation period.
Li N, Guthrie KA, Storer BE, Martin PJ, Sale GE, Argenyi ZB, Myerson D. Li N, et al. Biol Blood Marrow Transplant. 2012 Aug;18(8):1281-6. doi: 10.1016/j.bbmt.2012.02.001. Epub 2012 Feb 10. Biol Blood Marrow Transplant. 2012. PMID: 22326632 Free PMC article. - Management of acute graft-versus-host disease in children.
Carpenter PA, Macmillan ML. Carpenter PA, et al. Pediatr Clin North Am. 2010 Feb;57(1):273-95. doi: 10.1016/j.pcl.2009.11.007. Pediatr Clin North Am. 2010. PMID: 20307721 Free PMC article. Review. - Young rete ridge keratinocytes are preferred targets in cutaneous graft-versus-host disease.
Sale GE, Shulman HM, Gallucci BB, Thomas ED. Sale GE, et al. Am J Pathol. 1985 Feb;118(2):278-87. Am J Pathol. 1985. PMID: 3881975 Free PMC article. - Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.
Piguet PF, Grau GE, Allet B, Vassalli P. Piguet PF, et al. J Exp Med. 1987 Nov 1;166(5):1280-9. doi: 10.1084/jem.166.5.1280. J Exp Med. 1987. PMID: 3316469 Free PMC article.